Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Lung Neoplasms 10Hematopoietic and Lymphatic System Neoplasm 7Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Mouth Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Head and Neck Carcinoma 2Fallopian Tube Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Ureteral Neoplasms 1Tonsillar Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomatitis 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Endometrial Clear Cell Adenocarcinoma × Practice Guidelines as Topic × Clear all
NCT03422198 2025-12-12

SAVE

University of Utah

Phase 3 Recruiting
188 enrolled 15 charts
GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡